Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 82
- Developing broad-spectrum antiviral drugs for pandemic preparednessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- New AntiVirals for Infections with Pandemic PotentialFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- European Viral Outbreak Response AllianceFrom1 Jan 2024 → TodayFunding: HORIZON.1.3 - Research Infrastructures
- Classic and new strategies to fight alphavirusesFrom18 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Towards strategies for the treatment and prevention of henipavirus infections.From21 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
Publications
471 - 480 of 621
- Favipiravir (T-705) inhibits in vitro norovirus replication(2012)
Authors: Joana Duarte Da Rocha Pereira, Dirk Jochmans, Kai Dallmeier, Pieter Leyssen, Johan Neyts
Pages: 777 - 80 - Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection(2012)
Authors: Steven J Moss, Michael Bobardt, Pieter Leyssen, Nigel Coates, Udayan Chatterji, Xie Dejiand, Teresa Fpster, Jinlun Liud, Mohammad Nur-e-Alama, Dipen Suthara, et al.
Pages: 944 - 949 - Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection(2012)
Authors: Pieter Leyssen, Johan Neyts
Pages: 944 - 949 - The role of DC-SIGN and the mode of action of entry inhibitors in dengue virus infection(2012)
Authors: Marijke Alen, Dominique Schols, Johan Neyts
- The HCV non-nucleoside inhibitor tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function(2012)
Authors: Johan Neyts
- Novel 1,2,4-triazole and imidazole derivatives of l-ascorbic and imino-ascorbic acid: Synthesis, anti-HCV and antitumor activity evaluations(2012)
Authors: Pieter Leyssen, Johan Neyts, Jan Balzarini
Pages: 3675 - 85 - An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro(2012)
Authors: Tine De Burghgraeve, Suzanne Kaptein, Johan Neyts
- Synthesis of novel thienonorbornylpurine derivatives(2012)
Authors: Pieter Leyssen, Johan Neyts
Pages: 3195 - 3204 - Hepatocytes derived from human pluripotent stem cells permit complete replication of the hepatitis C virus(2012)
Authors: Philip Roelandt, Susan Obeid, Jolien Vanhove, Jan Paeshuyse, Kim Vanuytsel, Susanna Raitano, A Van Lommerl, Y Nahmias, Johan Neyts, Catherine Verfaillie, et al.
Pages: S54 - S55 - Efficient synthesis and anti-enteroviral activity of 9-arylpurines(2012)
Authors: Hendrik Jan Thibaut, Pieter Leyssen, Johan Neyts
Pages: 279 - 88
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)